Foetal haemoglobin-blood cells (F-cells) as a feature of embryonic tumours (blastomas)

British Journal of Cancer

Volumn 97, Issue 3, 2007, Pages 412-419

  Wolk, M ^a,b,c   Martin, J E ^a   Nowicki, M ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c NONE   (Israel)

Author keywords

Childhood cancer; DNA hypomethylation; Embryonic tumours; Foetal haemoglobin; Tumour marker

Indexed keywords

HEMOGLOBIN F;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL; BLOOD VESSEL; BONE MARROW; CANCER PATIENT; CELLULAR DISTRIBUTION; CHILD; DNA METHYLATION; ERYTHROBLAST; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR CELL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; FEMALE; FETAL HEMOGLOBIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; TUMOR MARKERS, BIOLOGICAL;

EID: 34547607296     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603867     Document Type: Article

References (33)

1. Atweh GF, Desimone J, Saunthararajha Y, Fathallah H, Weinberg RS, Nagel RL, Farby ME, Adams RJ (2003) Hemoglobinopathies. Hematology (Am Soc Hematol Educ Program) 14-39
2. Banelli B, Di Vinci A, Gelvi I, Cascimo I, Allemani G, Bonassi S, Romani M (2005) DNA methylation in neuroblastic tumors. Cancer Lett 228: 37-41
3. Brothman AR, Swanson G, Maxwell TM, Cui J, Murphy KJ, Herrick J, Speights VO, Isaac J, Rohr LR (2005) Global hypomethylation is common in prostate cancer cells: a quantitative predictor for clinical outcome? Cancer Genet Cytogenet 156: 31-36
4. Carr BI, Rahar S, Doroshow JH, Blayney D, Goldberg D, Leong L, Asmeron Y (1987) Fetal hemoglobin gene activation in phase II study of 5,6-dihydro-5-azacydine for bronchogenic carcinoma. Cancer Res 47: 4199-4201
5. Choi JW, Kim Y, Fujino M, Ito M (2002) F blast production correlates strongly with upregulation of inducible nitric oxide synthase in myelodysplastic syndromes. Ann Hematol 81: 548-550
6. Cope JU, Tsokos M, Miller RW (2001) Ewing sarcoma and sinonasal neuroectodermal tumors as second malignant tumors after retinoblastoma and other neoplasm. Med Pediatr Oncol 36: 290-294
7. De Benedittis M, Petruzzi M, Giardina C, Lo Muzio L, Pavia G, Serpico R (2004) Oral squamous cell carcinoma during long-term treatment with hydroxyurea. Clin Exp Dermatol 29: 605-607
8. Ehrlich M (2005) The controversial denouement of vertebrate DNA methylation research. Biochemistry (Mosc) 70: 568-575
9. Ehrlich M, Jiang G, Fiala E, Dome JS, Yu MC, Long TI, Youn B, Sohn OS, Widschwendter M, Tomlinson GE, Chintagumpala M, Champagne M, Parham D, Liang G, Malik K, Laird PW (2002) Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogenes 21: 6694-6702
10. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92
11. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonardt H, Jaenisch R (2003) Induction of tumors in mice by genomic hypomethylation. Science 300: 489-492
12. Itano O, Ueda M, Kikuchi K, Hashimoto O, Hayatsu S, Kawaguchi M, Seki H, Aiura K, Kitajima M (2002) Correlation of postoperative recurrence in hepatocellular carcinoma with demethylation of repetitive sequences. Oncogene 21: 789-797
13. King-Underwood l, REnshaw J, Pittchard-Jones K (1996) Mutations in the Wilms' tumor gene WT1 in leukemias. Blood 87: 2171-2179
14. Lavelle DE (2004) The molecular mechanism of fetal hemoglobin reactivation. Semin Hematol 41(Suppl 6): 3-10
15. Maiti S, Alam R, Amos C, Huff V (2000) Frequent association of β-catenin and WT1 mutations in Wilms tumors. Cancer Res 60: 6288-6292
16. Mares J, Kriz V, Weinhausel A, Vodickova S, Kodet R, Hass OA, Sedlacek Z, Goetz P (2001) Methylation changes in promoter and enhancer of WT1 gene in Wilms' tumors. Cancer Lett 166: 165-171
17. Markaki EA, Tsopanomichalou M, Dimitriou H, Stiakaki E, Perdikoyanni C, Spandidos D, Kalmanti M (2001) Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in children with acute leukemia and neuroblastoma. Pediat Hematol Oncol 18: 101-110
18. Mroczko B, Szmitkowski M, Okulczyk B (2003) Hematopoietic growth factors in colorectal cancer patients. Clin Chem Lab Med 41: 646-651
19. Nakagawa T, Kanai Y, Ushijima S, Kitamura T, Kakizoe T, Hirohashi S (2005) DNA hypomethylation on pericentromeric satellite regions significantly correlated with loss of heterozygosity on chromosome 9 in urothelial carcinoma. J Urol 173: 243-246
20. Rautonen J, Siimes A (1990) Initial blood fetal hemoglobin concentration is elevated and is associated with prognosis in children with acute lymphoid or myeloid leukemia. Blut 61: 17-20
21. Reinhardt D, Hasse D, Schoch C, Wollenweber S, Hinkelmann EV, Heyden W, Lentini G, Wormann B, Schroter W, Pekrun A (1998) Hemoglobin F in myelodispastic syndrome. Ann Hematol 76: 135-138
22. Sanchez F, Mateu E, Beneyto M, Najera C, Prieto F (2000) A constitutional homozygous mutation in the RB1 gene in apatient with unilateral retinoblastoma. J Med Genet 37: 615-620
23. Saunthararajah Y, Lavelle D, DeSimone J (2004) DNA hypo-methylating agents and sickle cell disease. Brit J Haematol 126: 629-636
24. van den Berg H (2002) Biology and therapy of malignant solid tumors in childhood. In: Giacone G, Schilski R, Sondel P (eds). Cancer Chemotherapy and Biological Response Modifiers. Ann 20. Elsevier Science B.V: The Netherlands, pp 605-625
25. Van den Eyden GG, Van Laere SJ, Vander Auwera I, Merajver SD, Van Marck EA, Van Dam P, Vermeulen PB, Dirix LY, Van Golen KL (2005) Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat Oct 22: 1-10
26. Wagner N, Wagner KD, Schley G, Coupland SE, Heiman H, Grantyn R, Scholz H (2002) The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells. Cell Growth Differ 13: 297-305
27. Wolk M, Kieselstein M, Gera Ben-Dor C, Brufman G (1991) Fetal hemoglobin screening in whole blood and in plasma of cancer patients. Tumor Biol 12: 45-51
28. Wolk M, Martin JE, Reinus C (2004) Blood cells with fetal haemoglobin (F-cells) detected by immunohistochemistry as indicators of solid tumors. J Clin Pathol 57: 740-745
29. Wolk M, Martin JE, Reinus C (2006) Development of fetal haemoglobin-blood cells (F cells) within colorectal tumour tissues. J Clin Pathol 59: 598-602
30. Wolk M, Newland AC, De La Salle B, Peleg M, Brufman G (1999) Refinement of plasma fetal hemoglobin (HbF) measurements, as related to whole blood HbF in cancer patients. J Tumor Marker Oncol 14: 115-124
31. Wolk M, Newlands ES (2004) The correlation between fetal hemoglobin and outcome in non-Hodgkin's lymphoma. The Internat. J Biol Markers 19: 168-169
32. Yamada Y, Jackson-Grusby L, Linhart H, Meissner A, Eden A, Lin H, Jaenisch R (2005) Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Aacad Sci USA 102: 13580-13585
33. Yoshida M, Nosaka K, Yasunaga JI, Nishikata I, Morishita K, Matsuoka M (2004) Aberrant expression of the MELIS gene identified in association with hypomethylation in adult T-cell leukaemia cells. Blood 103: 2753-2760